Find Clinical Trial

Evaluation of the clinical efficacy and safety of perindopril 5 mg / indapamide 1.25 mg / amlodipine 5 mg fixed combination in single-pill after 2 months of treatment versus free combination, perindopril 4 mg / indapamide 1.25 mg + amlodipine 5 mg given separately at the same time, with conditional titration based on blood pressure control in patients with essential hypertension uncontrolled after 1 month with perindopril 4 mg / indapamide 1.25 mg bi-therapy. A national, multicentre, randomised, double blind, 7 months study.

← Back
Study Phase

Phase 3

Therapeutic Area

Cardiovascular Diseases

SponsorInstitut de Recherches Internationales Servier (IRIS)
Active substance/
Medical device


Active Substance CodeS06593
Protocol CodeCL3-06593-018
NCT CodeNCT05820880

Documents and links

Lay summary
Results summary READ MORE

Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.

© 2024 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.